Computational Investigation of the Potential Antileishmanial Mechanism of the Nitroindazole Derivative VATR131
Authors:
- Omar Casanova-AlvarezOCOmar Casanova-Alvarez
- Niurka Mollineda-DiogoNMNiurka Mollineda-Diogo
- Aliuska Morales-HelgueraAMAliuska Morales-Helguera
- Vicente Arán-RedóVAVicente Arán-Redó
- Reinaldo Molina-RuizReinaldo Molina-Ruiz
- Norberto Sánchez-CruzNSNorberto Sánchez-Cruz
- Yendrek Velásquez-LópezYVYendrek Velásquez-López
- Yunierkis Perez-CastilloYPYunierkis Perez-Castillo
Open Access
- 3 October 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (10) , 1489
Abstract
Background: Neglected tropical diseases (NTDs) significantly impact global health, particularly affecting impoverished communities. Among these diseases, leishmaniasis, caused by protozoan parasites of the genus Leishmania and transmitted through sandfly vectors, remains a challenge due to limited therapeutic options. Current treatments often suffer from significant limitations, such as high toxicity, limited efficacy, and the emergence of drug resistance. Objectives: This study investigates the potential antileishmanial mechanism of action of nitroindazole derivatives, specifically evaluating the compound VATR131, a molecule with notable selectivity and potency against Leishmania infantum. Methods: We employed computational methodologies, including target fishing, molecular docking, and atomistic molecular dynamics simulations, to identify and characterize potential molecular targets of VATR131. Results: The analysis revealed cysteine peptidase A as a promising target potentially mediating the antileishmanial activity of VATR131. Molecular dynamics simulations suggest critical hydrophobic interactions and hydrogen bonds between the compound and its most likely receptor, thus offering deeper insights into its potential mechanism of action. Conclusions: These findings contribute to the development of novel and effective therapies for leishmaniasis, highlighting the need for experimental validation and continued investigation of nitroindazole derivatives as promising therapeutic candidates.Keywords
Funding Information
- International Collaboration Project “Strengthening and development of research capacities for the treatment of neglected and neglected parasitic diseases”
This publication has 65 references indexed in Scilit:
- In Vitro and In Vivo Antileishmanial Activity of ThioridazineActa Parasitologica, 2023
- Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2‐Benzyl‐5‐nitroindazole‐Derived AminesChemMedChem, 2018
- σ‐holes and π‐holes: Similarities and differencesJournal of Computational Chemistry, 2017
- Computational approaches in target identification and drug discoveryComputational and Structural Biotechnology Journal, 2016
- C-H…pi interactions in proteins: prevalence, pattern of occurrence, residue propensities, location, and contribution to protein stabilityJournal of Molecular Modeling, 2014
- The unique role of the nitro group in intramolecular interactions: chloronitromethanesStructural Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotesParasitology Research, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Miltefosine (Impavido): the first oral treatment against leishmaniasisMedical Microbiology and Immunology, 2003